Company Overview
Snapshot
Founded in February 2013 by Ehud Bendory and Eran Bendory, 3NT Medical operates with 11–50 employees. The company has raised $20.5M across three funding rounds, with Hoya Corporation as an investor. A significant milestone for the company was securing FDA clearance for its Colibri™ Endoscopy System in June 2020.
Business overview
3NT Medical develops advanced medical devices for nasal disorders, focusing on minimally invasive solutions. Its core product, the Sinusway single-use steerable endoscope, provides enhanced access, visualization, and treatment capabilities for the nasal anatomy. The company serves the healthcare industry, specifically targeting hospitals, clinics, and healthcare providers with its medical technologies, diagnostics, and surgical tools.
Strategic signal
In June 2020, 3NT Medical announced FDA clearance for its Colibri™ Endoscopy System. This regulatory approval is a critical validation for the company, enabling market entry and commercialization in the United States. For investors, this signals a significant de-risking event and opens up substantial growth opportunities within the medical device market, particularly for minimally invasive surgical procedures.
Company Intelligence Q&A
- When was 3NT Medical founded and by whom?
- 3NT Medical was founded in February 2013 by co-founders Ehud Bendory and Eran Bendory.
- What is 3NT Medical's primary product?
- 3NT Medical's primary product is the Sinusway single-use steerable endoscope, designed for minimally invasive access, visualization, and treatment of the nasal anatomy.
- Which regulatory approval did 3NT Medical receive in June 2020?
- In June 2020, 3NT Medical announced FDA clearance for its Colibri™ Endoscopy System.
- Which company invested in 3NT Medical in May 2018?
- In May 2018, Japan's Hoya Corporation invested in 3NT Medical as part of an initial closing of a $15M round.
- What is the total capital raised by 3NT Medical?
- 3NT Medical has raised a total of $20.5M across three funding rounds.